12 coronavirus stocks: another AIM share rallies 90%25 Apr 2020 08:07
https://www.ii.co.uk/analysis-commentary/12-coronavirus-stocks-another-aim-share-rallies-90-ii511416
"...That Scancellβs previous DNA vaccines, including cancer vaccine SCIB1, have been successful, has caused great optimism among investors. The technology is already shown to be safe and effective in cancer, and the company believes it should provide a more potent and long-lasting response than others being developed, ultimately leading to better immunity.
Whatβs more, the company claims that βthis new vaccine has the potential to generate protection not only against SARS-CoV-2 [the virus that causes Covid-19], but also against new strains of coronavirus that may arise in the future.β
Itβs this level of protection which sets it apart from other vaccines currently being developed. Initial research is underway and a Phase 1 clinical trial will only begin in Q1 2021, which is subject to funding. Scancell will need money from development partners, plus additional funding from governments and global institutions to support the rapid development of its vaccine."